Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Echocardiographic Changes of Carfilzomib Therapy in Multiple Myeloma Patients

Waled Bahaj, Anas Albawaliz, MD, Madeline E Begemann, RN, Anuj Shrestha, MD, Brett Sperry, MD, Shahzad Raza, MD

Blood (2020) 136 (Supplement 1): 34.

https://doi.org/10.1182/blood-2020-140090

Published: 2020

Journal Articles

An Open-Label Phase I/II Study of Carfilzomib, Bendamustine and Dexamethasone (CBD) in Newly Diagnosed Multiple Myeloma Patients

Siyang Leng, MD, Shahzad Raza, MD, Amer Assal, MD, Gregory Baliko, BS, Julia Gould, BA, Rachel K Shields, BA, Markus Y Mapara, MD PhD, Suzanne Lentzsch, MD PhD

Blood (2017) 130 (Supplement 1): 1863.

https://doi.org/10.1182/blood.V130.Suppl_1.1863.1863

Published: 2017

Journal Articles

Final Analysis of the Phase 1a/b Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients with Relapsed or Refractory AL Amyloidosis

Camille Vanessa Edwards, MBBS, BSc, Julia Gould, BA, Arielle L Langer, MD MPH, Markus Y Mapara, MD PhD, Jai Radhakrishnan, MD, Mathew S. Maurer, MD, Shahzad Raza, MD, John G. Mears, MD, Siyang Leng, MD, Jonathan S. Wall, PhD, Andrew Eisenberger, MD, Alan Solomon, MD, Suzanne Lentzsch, MD PhD

Blood (2017) 130 (Supplement 1): 509.

https://doi.org/10.1182/blood.V130.Suppl_1.509.509

Published: 2017

Journal Articles

Long Term Follow up of Patients with Relapsed/Refractory Systemic Light Chain (AL) Amyloidosis Treated with Bendamustine and Dexamethasone in a Phase 2 Study

Galina G. Lagos, MD, Suzanne Lentzsch, MD PhD, Raymond L. Comenzo, MD, Jeffrey A Zonder, MD, Keren Osman, MD, Julia Gould, BA, Wei-Yann Tsai, PhD, Silva Pregja, MBA, Mariamne Reyna, BS, Shahzad Raza, MD, Vaishali Sanchorawala, MD, Heather Landau, MD

Blood (2017) 130 (Supplement 1): 1838.

https://doi.org/10.1182/blood.V130.Suppl_1.1838.1838

Published: 2017

Journal Articles

Analysis of the Phase 1a/b Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients with AL Amyloidosis

Camille V Edwards, MD, Julia Gould, BA, Arielle L Langer, MD MPH, Markus Mapara, MD PhD, Jai Radhakrishnan, MD, Matthew S Maurer, MD, Shahzad Raza, MD, John G Mears, MD, Jonathan S Wall, PhD, Alan Solomon, MD, Suzanne Lentzsch, MD PhD

Blood (2016) 128 (22): 643.

https://doi.org/10.1182/blood.V128.22.643.643

Published: 2016

Journal Articles

Final Results of a Phase 2 Study of Bendamustine in Combination with Dexamethasone in Patients with Previously Treated Systemic Light-Chain (AL) Amyloidosis

Galina Grigoriev Lagos, MD, Suzanne Lentzsch, MD PhD, Raymond L. Comenzo, MD, Jeffrey Zonder, MD, Keren Osman, MD, Julia Gould, BA, Wei-Yann Tsai, Silva Pregja, MBA, Mariamne Reyna, BS, Shahzad Raza, MD, Vaishali Sanchorawala, MD, Heather Landau, MD

Blood (2016) 128 (22): 4523.

https://doi.org/10.1182/blood.V128.22.4523.4523

Published: 2016

Journal Articles

Updated Results of a Phase 2 Study of Bendamustine in Combination with Dexamethasone (Ben/Dex) in Patients with Previously-Treated Systemic Light-Chain (AL) Amyloidosis

Suzanne Lentzsch, MD PhD, Raymond L. Comenzo, MD, Jeffrey A Zonder, MD, Keren Osman, MD, Miao Susanna, Daniel Backenroth, Daniel Otap, Wei-Yann Tsai, Siva Pregja, Shahzad Raza, MD, Vaishali Sanchorawala, MD, Heather J Landau, MD

Blood (2015) 126 (23): 3041.

https://doi.org/10.1182/blood.V126.23.3041.3041

Published: 2015

Journal Articles

Results of Phase I Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients with AL Amyloidosis

Arielle L Langer, MD MPH, Susanna Miao, Markus Mapara, MD PhD, Jai Radhakrishnan, MD, Mathew S. Maurer, MD, Shahzad Raza, MD, John G. Mears, MD, Alan Solomon, MD, Suzanne Lentzsch, MD PhD

Blood (2015) 126 (23): 188.

https://doi.org/10.1182/blood.V126.23.188.188

Published: 2015

Journal Articles

Long Term Outcomes of First Line Tyrosine Kinase Inhibitors for Chronic Phase Chronic Myeloid Leukemia: A Mixed-Treatment Comparison

Belal Firwana, MD, Mohamad Bassam Sonbol, MD, Maria Diab, MD, Rim Hasan, MD, Ibraheem Yousef, MD, Archana Garipalli, MD, Shahzad Raza, MD, Aref Al-Kali, MD, Donald Doll, MD

Blood (2014) 124 (21): 3146.

https://doi.org/10.1182/blood.V124.21.3146.3146

Published: 2014

Journal Articles

Chronic Lymphocytic Leukemia-Associated Chromosomal Abnormalities and Risk of Secondary Malignancies

Shahzad Raza, MD, Paul J Hampel, BS/MDstudent, Belal Firwana, MD, Zhen Wang, PhD, Yasar Shad, MD, Lata Madhavi Aluri, MD, Uladzislau Naidzionak, MD, Donald C Doll, MD

Blood (2014) 124 (21): 5636.

https://doi.org/10.1182/blood.V124.21.5636.5636

Published: 2014

Journal Articles

A Restrospective Review Of Thrombophilia Evaluation At a Single Academic Institution

Uladzislau Naidzionak, MD, Katsiaryna Ivanova, MS, Shahzad Raza, MD, Donald Doll, MD

Blood (2013) 122 (21): 4796.

https://doi.org/10.1182/blood.V122.21.4796.4796

Published: 2013

NARROW

Echocardiographic Changes of Carfilzomib Therapy in Multiple Myeloma Patients

An Open-Label Phase I/II Study of Carfilzomib, Bendamustine and Dexamethasone (CBD) in Newly Diagnosed Multiple Myeloma Patients

Final Analysis of the Phase 1a/b Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients with Relapsed or Refractory AL Amyloidosis

Long Term Follow up of Patients with Relapsed/Refractory Systemic Light Chain (AL) Amyloidosis Treated with Bendamustine and Dexamethasone in a Phase 2 Study

Analysis of the Phase 1a/b Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients with AL Amyloidosis

Final Results of a Phase 2 Study of Bendamustine in Combination with Dexamethasone in Patients with Previously Treated Systemic Light-Chain (AL) Amyloidosis

Updated Results of a Phase 2 Study of Bendamustine in Combination with Dexamethasone (Ben/Dex) in Patients with Previously-Treated Systemic Light-Chain (AL) Amyloidosis

Results of Phase I Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients with AL Amyloidosis

Long Term Outcomes of First Line Tyrosine Kinase Inhibitors for Chronic Phase Chronic Myeloid Leukemia: A Mixed-Treatment Comparison

Chronic Lymphocytic Leukemia-Associated Chromosomal Abnormalities and Risk of Secondary Malignancies

A Restrospective Review Of Thrombophilia Evaluation At a Single Academic Institution

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only